UK Approves Weekly 'Onswik' Insulin for Type 2 Diabetes Treatment

The Medicines and Healthcare products Regulatory Agency (MHRA) has officially approved Onswik, a new insulin treatment for adults living with type 2 diabetes. Authorized on 13 October 2026, this long-acting basal insulin is designed to be administered only once per week. Unlike traditional daily insulin therapies, this medication can significantly reduce the injection burden for suitable patients, potentially lowering the frequency from 365 injections per year to just 52. Extensive scientific reviews indicate that the weekly treatment provides glycemic control comparable to current daily basal insulin regimens.

For the Turkish-speaking community and other residents in the UK, this development offers a potentially less invasive way to manage chronic diabetes treatment. Reducing the frequency of daily injections may help patients better adhere to their care plans and improve their daily routines. However, healthcare professionals emphasize that this does not apply to all diabetic patients, as some may still require supplementary treatments. Patients are strictly advised not to modify their current prescribed regimens without consulting their doctors, pharmacists, or specialist nurses.

The implementation of this drug within the National Health Service (NHS) will be determined following final guidance from the National Institute for Health and Care Excellence (NICE). While the MHRA authorization is a critical milestone, the specific criteria for which patient groups will receive the treatment via the NHS remain subject to further official guidance. The MHRA has highlighted hypoglycemia as the most common side effect and encourages patients to report any adverse reactions through the official Yellow Card system. The safety of the medication will continue to be monitored closely by regulators as it enters clinical use. This innovation marks a notable shift in the long-term management of type 2 diabetes by offering a more convenient, less frequent dosing schedule.

This summary was prepared with AI assistance. Please verify accuracy via the source.

Source: Olay Gazete